We are delighted to announce that Zeus has been appointed as Joint Broker to Avacta Group plc.
Avacta Therapeutics (AIM: AVCT) is a clinical stage biotechnology company expanding the reach of highly potent cancer therapies with the pre|CISION® platform. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.
Zeus Team
James Hornigold, Dominic King and George Duxberry.
Contact
If you would like further information, please get in touch with our team.